Alex Oshmyansky

In this enlightening conversation, Alex Oshmyansky, CEO and co-founder of Cost Plus Drugs, shares his journey from a young immigrant to a transformative force in the pharmaceutical industry. He discusses how the company is breaking down traditional drug pricing barriers with transparency and technology, revolutionizing access to medications. Oshmyansky also touches on his experiences transitioning from medicine to entrepreneurship, patience as a superpower, and the strategic partnerships that turned competitors into allies, all while advocating for affordable healthcare.

In this engaging conversation, Alex Oshmyansky, the CEO of Mark Cuban Cost Plus Drug Company and a practicing radiologist, discusses his mission to create a parallel supply chain to lower drug costs. He delves into the 'financial engineering' of the industry and the importance of transparency. Later, AJ Loiacono, CEO of CapitalRx, highlights the opaque nature of pharmacy benefit managers (PBMs) and their effect on pricing. Both guests passionately advocate for innovative solutions to revolutionize prescription drug accessibility and transparency.